Skip to main content
. 2019 Oct 11;20(6):5021–5031. doi: 10.3892/mmr.2019.10736

Table I.

Differentially expressed lncRNAs, miRNAs and mRNAs between HCC and adjacent normal tissues.

mRNA miRNA lncRNA



Symbol FDR logFC Symbol FDR logFC Symbol FDR logFC
HAMP 3.03E-15 −4.16 hsa-miR-9-5p 2.36E-15 4.35 KIAA0087 6.00E-04 0.86
KCNN2 4.13E-24 −3.99 hsa-miR-431-5p 1.71E-13 4.02 SNHG9 1.73E-03 −1.44
CXCL14 7.95E-28 −3.98 hsa-miR-301b 8.99E-13 3.87 LINC02203 2.01E-03 1.81
CNDP1 1.25E-19 −3.75 hsa-miR-216b-5p 1.59E-12 3.87 H19 3.55E-03 0.97
FCN2 6.81E-23 −3.64 hsa-miR-483-3p 1.51E-11 3.61 WWC2-AS2 5.30E-03 0.82
IGFBP3 1.61E-16 −2.08 hsa-miR-7974 1.45E-10 3.48 HNF1A-AS1 1.00E-02 0.87
RRM2 1.78E-15 2.25 hsa-miR-323a-3p 3.79E-10 3.37 TTTY6B 1.10E-02 0.70
STEAP3 4.73E-13 −1.48 hsa-miR-483-5p 4.78E-10 3.29 FAM138B 1.27E-02 1.16
ALDH1B1 9.83E-12 −1.16 hsa-miR-200c-3p 8.07E-10 3.25 WEE2-AS1 1.30E-02 0.54
ACSL4 1.83E-11 2.81 hsa-miR-183-5p 1.92E-09 3.15 HLA-F-AS1 1.38E-02 −0.90
CCNE2 7.91E-10 1.42 hsa-miR-410-3p 2.90E-09 3.11 LINC00284 1.80E-02 −0.61
GLS2 1.03E-09 −2.40 hsa-miR-182-5p 8.38E-07 2.53 SNHG15 1.83E-02 −0.54
CA2 6.67E-09 −1.24 hsa-miR-34c-5p 3.03E-06 2.46 DLGAP1-AS1 2.01E-02 −0.71
GADD45B 7.04E-09 −1.25 hsa-miR-7-5p 3.77E-05 2.14 KMT2E-AS1 2.12E-02 −0.68
ACAA2 2.51E-08 −1.01 hsa-miR-299-3p 4.17E-05 2.11 LINC00339 2.14E-02 −0.72
FAS 2.03E-07 −1.03 hsa-miR-15b-5p 1.37E-04 1.94 MAP3K14-AS1 2.19E-02 0.76
ACSL1 6.24E-07 −1.09 hsa-miR-30c-2-3p 1.97E-03 −1.61 LINC00909 2.72E-02 −0.60
THBS1 1.46E-06 −1.56 hsa-miR-149-5p 9.85E-03 1.35 SRRM2-AS1 3.78E-02 −0.99
ACADSB 1.30E-05 −1.03 hsa-miR-214-5p 1.89E-02 −1.22 LINC00928 4.00E-02 −0.75
CPS1 1.75E-03 −1.24 hsa-miR-128-3p 2.36E-02 1.17 RUSC1-AS1 4.06E-02 −1.03

lncRNAs, long non-coding RNAs; miRNAs, microRNAs; HCC, hepatocellular carcinoma; FC, fold change; FDR, false discovery rate; CCNE2, cyclin E2; RRM2, ribonucleotide reductase M2 subunit.